Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 2647 | 16.76 |
09:34 ET | 884 | 16.84 |
09:36 ET | 100 | 16.83 |
09:38 ET | 163 | 16.74 |
09:43 ET | 400 | 16.75 |
09:45 ET | 100 | 16.75 |
09:48 ET | 100 | 16.75 |
09:50 ET | 2627 | 17.07 |
09:54 ET | 200 | 16.99 |
09:57 ET | 560 | 16.8701 |
09:59 ET | 3298 | 16.93 |
10:01 ET | 1038 | 16.91 |
10:03 ET | 300 | 16.875 |
10:06 ET | 592 | 16.86 |
10:08 ET | 530 | 16.82 |
10:10 ET | 300 | 16.78 |
10:12 ET | 831 | 16.89 |
10:14 ET | 3183 | 16.84 |
10:15 ET | 300 | 16.71 |
10:17 ET | 876 | 16.78 |
10:19 ET | 100 | 16.78 |
10:26 ET | 100 | 16.76 |
10:28 ET | 897 | 16.74 |
10:30 ET | 600 | 16.8 |
10:32 ET | 665 | 16.74 |
10:33 ET | 383 | 16.69 |
10:35 ET | 1174 | 16.705 |
10:37 ET | 114 | 16.74 |
10:39 ET | 100 | 16.8 |
10:42 ET | 100 | 16.815 |
10:44 ET | 200 | 16.84 |
10:48 ET | 100 | 16.82 |
10:50 ET | 469 | 16.83 |
10:51 ET | 300 | 16.84 |
10:55 ET | 100 | 16.88 |
10:57 ET | 345 | 16.91 |
11:00 ET | 773 | 16.95 |
11:02 ET | 1116 | 16.95 |
11:04 ET | 463 | 16.91 |
11:08 ET | 617 | 16.95 |
11:09 ET | 400 | 16.865 |
11:13 ET | 2584 | 16.81 |
11:15 ET | 105 | 16.825 |
11:18 ET | 791 | 16.73 |
11:22 ET | 100 | 16.71 |
11:24 ET | 100 | 16.68 |
11:26 ET | 109 | 16.6742 |
11:27 ET | 629 | 16.665 |
11:29 ET | 1364 | 16.74 |
11:31 ET | 210 | 16.72 |
11:38 ET | 100 | 16.67 |
11:40 ET | 743 | 16.68 |
11:42 ET | 100 | 16.65 |
11:44 ET | 400 | 16.63 |
11:47 ET | 1602 | 16.63 |
11:49 ET | 1003 | 16.64 |
11:51 ET | 106 | 16.67 |
11:54 ET | 415 | 16.64 |
11:56 ET | 200 | 16.65 |
12:00 ET | 852 | 16.61 |
12:02 ET | 589 | 16.59 |
12:03 ET | 170 | 16.57 |
12:07 ET | 100 | 16.56 |
12:09 ET | 866 | 16.5975 |
12:12 ET | 1713 | 16.54 |
12:14 ET | 532 | 16.53 |
12:20 ET | 1600 | 16.53 |
12:21 ET | 240 | 16.52 |
12:23 ET | 100 | 16.52 |
12:25 ET | 430 | 16.51 |
12:27 ET | 256 | 16.48 |
12:30 ET | 454 | 16.485 |
12:32 ET | 111 | 16.48 |
12:34 ET | 561 | 16.43 |
12:38 ET | 501 | 16.46 |
12:39 ET | 829 | 16.5 |
12:41 ET | 635 | 16.47 |
12:45 ET | 1299 | 16.54 |
12:50 ET | 701 | 16.52 |
12:52 ET | 300 | 16.5 |
12:54 ET | 100 | 16.5 |
12:56 ET | 100 | 16.515 |
12:57 ET | 100 | 16.515 |
12:59 ET | 900 | 16.52 |
01:06 ET | 400 | 16.5 |
01:14 ET | 2067 | 16.49 |
01:15 ET | 3444 | 16.49 |
01:17 ET | 132 | 16.49 |
01:19 ET | 300 | 16.49 |
01:21 ET | 224 | 16.485 |
01:24 ET | 1358 | 16.53 |
01:26 ET | 115 | 16.55 |
01:30 ET | 700 | 16.5236 |
01:32 ET | 700 | 16.55 |
01:33 ET | 900 | 16.595 |
01:35 ET | 1006 | 16.65 |
01:37 ET | 1582 | 16.67 |
01:39 ET | 1630 | 16.63 |
01:42 ET | 400 | 16.65 |
01:44 ET | 200 | 16.65 |
01:46 ET | 205 | 16.68 |
01:48 ET | 100 | 16.695 |
01:50 ET | 507 | 16.68 |
01:51 ET | 200 | 16.68 |
01:53 ET | 200 | 16.675 |
01:57 ET | 600 | 16.665 |
02:00 ET | 1289 | 16.715 |
02:02 ET | 2532 | 17.11 |
02:04 ET | 1705 | 17.23 |
02:06 ET | 2047 | 17.2 |
02:08 ET | 5726 | 17.05 |
02:09 ET | 3887 | 16.83 |
02:11 ET | 673 | 16.83 |
02:13 ET | 3945 | 16.61 |
02:15 ET | 3330 | 16.73 |
02:18 ET | 2679 | 16.86 |
02:20 ET | 1300 | 16.9 |
02:22 ET | 4435 | 16.96 |
02:24 ET | 4532 | 16.965 |
02:26 ET | 3490 | 16.99 |
02:27 ET | 3276 | 17.11 |
02:29 ET | 1646 | 17.11 |
02:31 ET | 18252 | 17 |
02:33 ET | 18990 | 17 |
02:36 ET | 4180 | 17 |
02:38 ET | 4750 | 16.86 |
02:40 ET | 2200 | 16.99 |
02:42 ET | 934 | 16.96 |
02:44 ET | 1581 | 16.875 |
02:45 ET | 1100 | 16.7 |
02:47 ET | 2371 | 16.91 |
02:49 ET | 1405 | 16.86 |
02:51 ET | 945 | 16.855 |
02:54 ET | 1357 | 16.98 |
02:56 ET | 462 | 16.95 |
02:58 ET | 1275 | 16.97 |
03:00 ET | 100 | 16.99 |
03:02 ET | 786 | 16.77 |
03:03 ET | 2057 | 16.76 |
03:05 ET | 200 | 16.75 |
03:07 ET | 1571 | 16.6403 |
03:09 ET | 907 | 16.67 |
03:12 ET | 1980 | 16.7 |
03:14 ET | 2344 | 16.82 |
03:16 ET | 2193 | 16.865 |
03:18 ET | 1200 | 16.815 |
03:20 ET | 1900 | 16.78 |
03:21 ET | 1378 | 16.68 |
03:23 ET | 2233 | 16.69 |
03:25 ET | 700 | 16.72 |
03:27 ET | 2806 | 16.79 |
03:30 ET | 2035 | 16.815 |
03:32 ET | 2673 | 16.76 |
03:34 ET | 2071 | 16.765 |
03:36 ET | 1700 | 16.67 |
03:38 ET | 1321 | 16.625 |
03:39 ET | 3265 | 16.7 |
03:41 ET | 3051 | 16.645 |
03:43 ET | 6556 | 16.61 |
03:45 ET | 3175 | 16.59 |
03:48 ET | 4328 | 16.55 |
03:50 ET | 5402 | 16.52 |
03:52 ET | 5406 | 16.545 |
03:54 ET | 7261 | 16.54 |
03:56 ET | 5395 | 16.59 |
03:57 ET | 9630 | 16.555 |
03:59 ET | 104038 | 16.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.5B | -5.3x | --- |
Ardelyx Inc | 1.4B | -21.2x | --- |
Gyre Therapeutics Inc | 1.3B | -16.1x | --- |
Nurix Therapeutics Inc | 1.6B | -8.5x | --- |
Xencor Inc | 1.5B | -7.2x | --- |
Arvinas Inc | 1.7B | -4.7x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.